Tiffany Ayres
Boxer Capital Management, Llc
Assets Managed
$761.654M
Holdings
54
Last Quarter
2026 - Q1
Filed Date
14d ago
Growth Rate
66.71%(2Q avg: 56.17%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Boxer Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 54 positions.
Assets under management
The assets under management (AUM) of Boxer Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 761.654M in assets, with a quarterly growth rate of 66.71% and a 2-quarter average growth rate of 56.17%. The portfolio is managed by Tiffany Ayres, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
TNGX Tango Therapeutics Inc
| 29.88% | $227.531M 10.876M shares@ $20.92 avg price | |
KOD Kodiak Sciences Inc
| 6.82% | $51.881M 1.361M shares@ $38.12 avg price | Increased 19.81% |
RVMD Revolution Medicines Inc
| 6.39% | $48.625M 500,000 shares@ $97.25 avg price | Increased 25% |
KYMR Kymera Therapeutics Inc
| 3.6% | $27.411M 329,100 shares@ $83.29 avg price | |
CELC Celcuity Inc
| 3.38% | $25.681M 225,000 shares@ $114.14 avg price | |
SRZN Surrozen Inc
| 2.94% | $22.323M 766,318 shares@ $29.13 avg price | Increased 84.15% |
ABVX Abivax Sa-adr
| 2.93% | $22.27M 200,000 shares@ $111.35 avg price | Increased 60% |
TERN Terns Pharmaceuticals Inc
| 2.6% | $19.77M 375,000 shares@ $52.72 avg price | |
PCVX Vaxcyte Inc
| 2.48% | $18.886M 325,000 shares@ $58.11 avg price | New Position |
CAPR Capricor Therapeutics Inc
| 2.36% | $17.936M 590,000 shares@ $30.4 avg price | Increased 81.54% |
1-10 of 54